Moderator: Colin Hill, Chief Executive Officer, President & Chairman, GNS Healthcare Panelists: Alexis Borisy, Entrepreneur in Residence, Third Rock Ventures Joel Dudley, PhD, Director of Biomedical Informatics and Assistant Professor of Genetics and Genomics Sciences, Icahn School of Medicine at Mount Sinai Brian Leyland-Jones, MD, VP, Molecular and Experimental Medicine, Avera Health Michael Kolodziej, MD, […]
Brain Cancer – Tackling the Intractable: Novel Targets and Approaches
Moderator: Minesh P. Mehta, MD, Medical Director, Maryland Proton Treatment Center, University of Maryland Panelists: Lauren Abrey, MD, Oncology Development Site Head, F. Hoffmann-La Roche Inc. Thomas Davis, MD, CMO and SVP Clinical Development, Celldex Therapeutics H. Ian Robins, MD, PhD, Faculty, University of Wisconsin School of Medicine and Public Health Eric Rowinsky, MD, Chief […]
New Treatment Options for Prostate Cancer
After decades of incremental progress, at best, in treating advanced prostate cancer, men with androgen independent disease now have many different treatment options. Since 2010, 5 new drugs representing 4 different treatment strategies that offer not only symptom relief, but also longer survival, have been approved by the FDA. Furthermore, stimulated by this success, there […]